Biodesix (NASDAQ:BDSX – Get Free Report) had its price target upped by research analysts at Canaccord Genuity Group from $22.00 to $27.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 68.75% from the stock’s current [...]
Biodesix (NASDAQ:BDSX) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
